Legal & General Group
PRCT icon

Legal & General Group’s Procept Biorobotics PRCT Stock Holding History

Legal & General Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$960K Buy
42,495
+2,768
+7% +$69.3K ﹤0.01% 2218
2026
Q1 		$994K Sell
39,727
-11,756
-23% -$331K ﹤0.01% 2145
2025
Q4 		$1.62M Sell
51,483
-6,708
-12% -$222K ﹤0.01% 2057
2025
Q3 		$2.08M Buy
58,191
+272
+0.5% +$12.4K ﹤0.01% 1965
2025
Q2 		$3.34M Buy
57,919
+5,752
+11% +$325K ﹤0.01% 1742
2025
Q1 		$3.04M Buy
52,167
+2,196
+4% +$150K ﹤0.01% 1757
2024
Q4 		$4.02M Buy
49,971
+1,080
+2% +$92.3K ﹤0.01% 1686
2024
Q3 		$3.92M Buy
48,891
+3,839
+9% +$273K ﹤0.01% 1684
2024
Q2 		$2.75M Buy
45,052
+299
+0.7% +$17.8K ﹤0.01% 1798
2024
Q1 		$2.21M Buy
44,753
+1,172
+3% +$55.8K ﹤0.01% 1899
2023
Q4 		$1.83M Buy
43,581
+5,114
+13% +$174K ﹤0.01% 1995
2023
Q3 		$1.26M Buy
38,467
+4,611
+14% +$157K ﹤0.01% 2103
2023
Q2 		$1.2M Buy
33,856
+26,796
+380% +$886K ﹤0.01% 2147
2023
Q1 		$201K Buy
7,060
+217
+3% +$7.65K ﹤0.01% 2590
2022
Q4 		$284K Buy
6,843
+295
+5% +$12.7K ﹤0.01% 2485
2022
Q3 		$271K Sell
6,548
-2,747
-30% -$110K ﹤0.01% 2510
2022
Q2 		$304K Buy
9,295
+8,585
+1,209% +$312K ﹤0.01% 2491
2022
Q1 		$25K Hold
710
– – ﹤0.01% 3178
2021
Q4 		$18K Buy
+710
New +$26.3K ﹤0.01% 3311

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Legal & General Group's PRCT Position: Q2 2026 in Review

Legal & General Group increased its Procept Biorobotics (PRCT) stake by 7% in Q2 2026, buying an estimated $69.3K and bringing the position to 42,495 shares worth $960K. The position accounts for ﹤0.01% of the portfolio, ranked #2218.

Legal & General Group first reported a position in PRCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.02M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Legal & General Group held 42,495 shares of Procept Biorobotics worth $960K as of Q2 2026.
  • Legal & General Group bought 2,768 Procept Biorobotics shares in Q2 2026, an estimated $69.3K.
  • Procept Biorobotics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2218 holding.
  • Legal & General Group first reported a position in Procept Biorobotics in Q4 2021 and has held it in 19 quarters since.
  • Legal & General Group's Procept Biorobotics position peaked at $4.02M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.